Children's Oncology Group's 2013 blueprint for research: Radiation oncology

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pediatric Blood & Cancer

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pbc.24425PMID 23255526PMCID PMC4709221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac-sparing whole lung IMRT in children with lung metastasis.

  2013cited by this paper
• Advantages of whole-liver intensity modulated radiation therapy in children with Wilms tumor and liver metastasis.

  2013cited by this paper
• Novel assessment of renal motion in children as measured via four-dimensional computed tomography.

  2012cited by this paper
• Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.

  2012cited by this paper
• Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934.

  2012cited by this paper
• Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.

  2012cited by this paper
• Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Children's Oncology Group

  2011cited by this paper
• Inter- and intrafractional positional uncertainties in pediatric radiotherapy patients with brain and head and neck tumors.

  2011cited by this paper
• Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group.

  2011cited by this paper
• [Intensity-modulated radiotherapy and involved-node concept in patients with Hodgkin lymphoma: experience of the Gustave-Roussy Institute].

  2011cited by this paper
• Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.

  2010cited by this paper
• Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group.

  2010cited by this paper
• Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

  2010cited by this paper
• Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

  2009cited by this paper
• Estimating differences in volumetric flat bone growth in pediatric patients by radiation treatment method.

  2007cited by this paper
• POG 8625: A Randomized Trial Comparing Chemotherapy With Chemoradiotherapy for Children and Adolescents With Stages I, IIA, IIIA1 Hodgkin Disease: A Report from the Children's Oncology Group

  2006cited by this paper
• Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.

  2006cited by this paper
• Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.

  2006cited by this paper
• Differential attenuation of clavicle growth after asymmetric mantle radiotherapy.

  2004cited by this paper
• Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials.

  2003cited by this paper
• Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

  2003cited by this paper
• Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

  2001cited by this paper

• The future of pediatric oncology: Comprehensive review of causes, mortality, and treatment strategies

  2026cites this paper
• Dual Inhibition of MAPK and TORC1 Signaling Retards Development of Radiation Resistance in Pediatric BRAFV600E Glioma Models.

  2025cites this paper
• Advances in the treatment of BRAF-mutant low-grade glioma with MAPK inhibitors

  2023cites this paper
• Children's Oncology Group's 2023 blueprint for research: Radiation oncology

  2023cites this paper
• Impact of Volumetric Dosimetry on the Projected Cost of Radiation-Related Late Effects Screening After Childhood Cancer: A Real-World Cohort Analysis

  2023cites this paper
• Surveillance for radiation‐related late effects in childhood cancer survivors: The impact of using volumetric dosimetry

  2020cites this paper
• Leptomeningeal malignancy of childhood: sharing learning between childhood leukaemia and brain tumour trials.

  2020cites this paper
• How do patient characteristics and anatomical features correlate to accuracy of organ dose reconstruction for Wilms’ tumor radiation treatment plans when using a surrogate patient’s CT scan?

  2019cites this paper
• Trajectories of psychosocial and cognitive functioning in pediatric patients with brain tumors treated with radiation therapy.

  2019cites this paper
• Proton Therapy for Pediatric Malignancies

  2018cites this paper
• Patterns of relapse for children with localized intracranial ependymoma

  2018cites this paper
• Are age and gender suitable matching criteria in organ dose reconstruction using surrogate childhood cancer patients’ CT scans?

  2018cites this paper
• Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors

  2017cites this paper
• Risk stratification and therapeutics of neuroblastoma: the challenges remain

  2016cites this paper
• A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer

  2016cites this paper
• Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.

  2015cites this paper
• Proton therapy for the treatment of children with CNS malignancies.

  2014cites this paper
• Proton beam therapy: a fad or a new standard of care

  2014cites this paper
• Photons or protons for non-central nervous system solid malignancies in children: a historical perspective and important highlights.

  2013cites this paper
• Put yourself in their shoes … the vulnerability of children and their families when attending for radiotherapy treatment: The role of the specialist paediatric radiotherapy radiographer

  2013cites this paper